Shopping Cart
- Remove All
- Your shopping cart is currently empty
Lifirafenib (BGB-283) maleate, a novel inhibitor targeting both Raf Kinase and EGFR, exhibits potent activity with IC50 values of 23 nM and 29 nM against recombinant BRaf V600E and EGFR, respectively [1].
Pack Size | Price | Availability | Quantity |
---|---|---|---|
10 mg | Inquiry | 10-14 weeks | |
50 mg | Inquiry | 10-14 weeks |
Description | Lifirafenib (BGB-283) maleate, a novel inhibitor targeting both Raf Kinase and EGFR, exhibits potent activity with IC50 values of 23 nM and 29 nM against recombinant BRaf V600E and EGFR, respectively [1]. |
Alias | BGB-283 maleate |
Molecular Weight | 652.53 |
Formula | C25H17F3N4O3.3/2C4H4O4 |
Cas No. | 1854985-74-2 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.